Team

Scientific leadership,
patient-centred outreach.

KritRNA is led by two equal co-founders: scientific and technology development under Dr. Nikhil Bharti, and outreach, awareness and stakeholder engagement under Pragati Bhaisora.

Dr. Nikhil Bharti

Dr. Nikhil Bharti

Scientific Co-Founder & Director · CSO / CTO

Molecular biologist focused on translation regulation and tRNA biology. Leads scientific strategy, platform architecture and experimental-validation planning.

Pragati Bhaisora

Pragati Bhaisora

Co-Founder & Director · Outreach & Awareness Strategist

Leads rare-disease outreach, awareness, stakeholder communication and patient-community engagement, with equal co-founder responsibility for building KritRNA.

Extended network

Building the company around the founders

These sections show the active build and advisory network. Status language is retained until appointments and institutional relationships are formally confirmed.

AI / ML & computational biology build
Additional AI / ML developer
Computational-development role currently under discussion; appointment not yet announced.
Scientific & clinical advisory
Sandeep M. Eswarappa
Scientific-advisor onboarding and paperwork underway.
Additional scientific advisors
Approached; names will be announced only after formal confirmation.
LNJP Hospital — Genetics Department
Clinical-advisory discussions initiated; individual clinicians will be named after formal confirmation.
Scientific foundation

Founder research record

The complete publication set currently used in company materials is shown below. Where a persistent article link is still being cross-checked, the entry is labelled rather than guessed.

2024
Nature Communications
Translation velocity and suppressor-tRNA efficacy

First-author research on translation dynamics and suppressor-tRNA performance. Full bibliographic details are being cross-checked before final publication.

First author
2023
Journal of Biological Chemistry
tRNA biology and translation regulation

Co-authored work in tRNA biology and translational regulation. Full bibliographic details are being cross-checked before final publication.

Co-author

This is a founder publication record. No former university or laboratory is represented as a current company affiliation or endorsement.